FDA Rejects Amgen's Biosimilars Info-Sharing Petition
The U.S. Food and Drug Administration in a letter released Thursday rejected Amgen Inc.'s request that biosimilars makers be forced to share their applications and manufacturing processes with competitors, exacerbating the...To view the full article, register now.
Already a subscriber? Click here to view full article